Target intelligence / Profile preview

MicroRNA 3120 (miR-3120)

Target
miR-3120
Molecular classification
microRNA, non-coding RNA, RNA gene
01

Overview

MicroRNA 3120 (miR-3120) is a short, non-coding RNA molecule processed from an intronic region of the dynamin-3 gene. It is classified as a “mirror” microRNA because it is produced from the sense strand of the locus, while the antisense strand encodes miR-214. miR-3120 is primarily found in neuronal cells, where it regulates key aspects of vesicle trafficking by directly targeting the mRNAs of heat shock cognate protein 70 (Hsc70, also known as HSPA8) and the co-chaperone auxilin. By downregulating these targets, miR-3120 inhibits the uncoating of clathrin-coated vesicles, a critical step in synaptic vesicle recycling and endocytosis. Although it plays a specific, well-characterized role in neural vesicle cycling, miR-3120 is not regarded as a conventional therapeutic target such as a receptor, enzyme, or transporter. There are currently no recognized drugs that interact directly with miR-3120, and it is not used as a biomarker or therapeutic agent[1][3][4][7]. Note: - miR-3120 should not be confused with protein-coding genes or classical drug targets; it is a regulatory RNA with specialized functions primarily documented in neurons. - Disease roles, clinical utility, and safety concerns are not well characterized, and no direct therapeutic interventions—or drugs—target this microRNA.

Other names
hsa-mir-3120mir-3120MIR3120hsa-mir-3120-5phsa-mir-3120-3p
02

Biological functions

Post-transcriptional regulation of gene expressionRegulation of mRNA stability and translationRegulation of clathrin-mediated endocytosisModulation of Hsc70 and auxilin expressionRegulation of vesicle uncoating processes in neurons
03

Disease associations

Potential roles suggested in neurological function and synaptic vesicle recycling, but no specific disease association established

Beyond the preview

Go deeper on MicroRNA 3120 (miR-3120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3120 (miR-3120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call